Suggested Topics within your search.
Showing 1 - 20 results of 72 for search '"Ramucirumab"', query time: 1.05s Refine Results
  1. 1
    Long-Term Survival in Gastroesophageal Junction Adenocarcinoma: Ramucirumab
    Subjects: “...Ramucirumab...”
    Get full text
    Article
  2. 2
    Potential of ramucirumab in treating hepatocellular carcinoma patients with elevated baseline alpha-fetoprotein
    by Gilabert M, Raoul JL
    Published 2018-11-01
    Subjects: “...ramucirumab...”
    Get full text
    Article
  3. 3
    Efficacy and Safety of Ramucirumab in Asian and Non-Asian Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Individual Data Analysis of Two Randomized Studies
    Subjects: “...ramucirumab...”
    Get full text
    Article
  4. 4
    Ramucirumab, A Second-Line Option For Patients With Hepatocellular Carcinoma: A Review Of The Evidence
    by De Luca E, Marino D, Di Maio M
    Published 2020-05-01
    Subjects: “...ramucirumab...”
    Get full text
    Article
  5. 5
    Phase II study of ramucirumab and docetaxel for previously treated non‐small cell lung cancer patients with malignant pleural effusion: Protocol of PLEURAM study
    Subjects: “...ramucirumab...”
    Get full text
    Article
  6. 6
    Clinical significance of primary prophylactic pegylated‐granulocyte‐colony stimulating factor after the administration of ramucirumab plus docetaxel in patients with previously treated non‐small cell lung cancer
    Subjects: “...ramucirumab...”
    Get full text
    Article
  7. 7
    Second-line treatment for advanced NSCLC without actionable mutations: is immunotherapy the ‘panacea’ for all patients?
    by Alessandro Morabito
    Published 2018-02-01
    Subjects: “...Ramucirumab...”
    Get full text
    Article
  8. 8
    Profile of ramucirumab in the treatment of metastatic non-small-cell lung cancer
    by Cooper MR, Binkowski C, Hartung J, Towle J
    Published 2016-04-01
    Subjects: “...ramucirumab...”
    Get full text
    Article
  9. 9
    Improved efficacy of ramucirumab plus docetaxel after nivolumab failure in previously treated non‐small cell lung cancer patients
    Subjects: “...ramucirumab...”
    Get full text
    Article
  10. 10
    Clinical example of enhancing efficacy of paclitaxel by combining it with ramuchirumabin in the second-line chemotherapy of disseminated gastric cancer
    by T. A. Titova, E. V. Artamonova, N. S. Besova
    Published 2019-06-01
    Subjects: “...ramucirumab...”
    Get full text
    Article
  11. 11
    REAL-LIFE CLINICAL UTILITY OF RAMUCIRUMAB FOR THE TREATMENT OF PATIENTS WITH DISSEMINATED GASTRIC ADENOCARCINOMA: PRELIMINARY REVIEW OF THE EXPERIENCE OF BLOKHIN RUSSIAN CANCER RESEARCH CENTRE
    Subjects: “...ramucirumab...”
    Get full text
    Article
  12. 12
    Retrospective observational study of salvage line ramucirumab monotherapy for patients with advanced gastric cancer
    Subjects: “...Ramucirumab...”
    Get full text
    Article
  13. 13
    Second‐line treatment of hepatocellular carcinoma after sorafenib: Characterizing treatments used over the past 10 years and real‐world eligibility for cabozantinib, regorafenib, and ramucirumab
    Subjects: “...ramucirumab...”
    Get full text
    Article
  14. 14
    Renal-limited thrombotic microangiopathy after switching from bevacizumab to ramucirumab: a case report
    Subjects: “...Ramucirumab...”
    Get full text
    Article
  15. 15
    Clinical role of ramucirumab alone or in combination with paclitaxel for gastric and gastro-oesophageal junction adenocarcinoma
    by Davidson M, Smyth EC, Cunningham D
    Published 2016-07-01
    Subjects: “...ramucirumab...”
    Get full text
    Article
  16. 16
    Unresectable Advanced Gastric Cancer with Skin Invasion followed by Total Gastrectomy after Second-Line Chemotherapy
    Subjects: “...Ramucirumab/Paclitaxel...”
    Get full text
    Article
  17. 17
    Preclinical assessment of intravitreal ramucirumab: in vitro and in vivo safety profile
    Subjects: “...Ramucirumab...”
    Get full text
    Article
  18. 18
    Results of the use of ramucirumab in combination with paclitaxel or ramucirumab monotherapy as the second line treatment in patients with disseminated HER2-negative gastric or cardioesophageal junction adenocarcinoma: experience of N.N. Blokhin russian cancer research center of the ministry of health of Russia
    Subjects: “...ramucirumab...”
    Get full text
    Article
  19. 19
    Ramucirumab combined with paclitaxel as the second-line chemotherapy for elderly patients with disseminated gastric cancer
    Subjects: “...ramucirumab...”
    Get full text
    Article
  20. 20
    Ramucirumab for Patients with Intermediate-Stage Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Results from Two Phase 3 Studies (REACH and REACH-2)
    Subjects: “...ramucirumab...”
    Get full text
    Article
Search Tools: Get RSS Feed — Email this Search